Click to download or view mobile version Author(s): Abstract or description: More Virtual Posters Real-world outcomes in patients with RA remaining on first-line TNFi Long-term maintenance of response of an IL-23i in PsA Time to first musculoskeletal response of an IL-23i in PsA Effectiveness of Interleukin-6 Receptor Inhibitors versus Conventional Synthetic Immunomodulatory Therapy for Treatment of Frail Patients with Polymyalgia Rheumatica ADD THE FIRST COMMENT If you are a health practitioner, you may Login/Register to comment.Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.